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1. Introduction 
Pemanent mixed-field poIyaggIutinability (PMFP) 
of human erythrocytes i a rare condition characterized 
by the presence of Tn antigen on the cell surface [11. 
The carbohydrate moiety of Tn antigen is a O- 
glycosidically linked o-i%acetylgalactosamine 
(GalNAc) [2] . In normal individuals the a-GaINAc 
residue is substituted with galactose (gal) in a P(l+3) 
linkage forming the ~omsen-F~edenreich (T) antigen 
[3], which is considered to be a precursor of the M 
and N blood~oups [4]. Based upon serological evi- 
dence, Sturgeon postulated abiosynthetic defect in 
PMFP consisting of a block in the transfer of D- 
galactose to the GalNAc [ 1 J . We have recently 
described asoluble galactosyltransferase ctivity in 
human serum which catalyzes agal /3( l-+3) GalNAc 
linkage [5] using sialic acid free ovine submaxillary 
mucin (Sf-OSM) as an exogenous ubstrate. We now 
present evidence of a similar membrane-bound 
galactosyltransferase: Sf-OSM activity from normal 
A or 0 erythrocytes of types M, MN or N, and the 
absence of this enzyme in Tn tr~sformed erythrocyte 
membranes from a patient (R.R.) in whom this 
condition was first observed in 1972 and last con- 
firmed in November 1977 (Dr M. N. Metaxas, personal 
communication). 
2. Material and methods 
ACD blood with blood type A and 0 from healthy 
donors was obtained from the Swiss Red Cross of 
Beme and Zurich. Tn erythrocytes were obtained 
from a patient whose PMFP was described in f 1 ] . 
The blood was kept at 4°C till further processing 
within 5 days. PIasrna was obtained by low speed 
centrifugation, the erythrocytes were washed several 
times with NaClO.9% (w/v). Membranes were obtained 
as in [6] . 
2.1. Galactosyltransferase assay 
The standard assay of galactosyltransferase ctivity 
using Sf-OSM, prepared as in [7], or ovalbumin 
(Sigma) included 100 pg e~~rocyte membrane 
protein in 150 &1,20 mM MnCls ,70 mM Na-cacodyl- 
ate, pH 7.35, Triton X-100 1 ggj@, 4 mg/ml Sf-OSM 
or 5.3 m&l ovalbumin, respectively and UDP- 
Galactose 0.2 mM (Sigma) to which 1 PCi UDP-[‘II] 
galactose (Amersham, 16.3 Ci/mmol) has been added. 
The mixture was incubated for 4 h at 30°C and 
stopped by adding an excess of ice-cold phospho- 
tungstic acid 2% (w/v) in 2 N HCl. The precipitate 
was filtered over glass fiber filters and washed with 
cold ethanol. The filters were dried, placed in vials to 
which 10 mI toiuene-butyl-PBD (Ciba-Geim) 0.8% 
(w/v) was added. ~~oacti~ty was determined in a 
liquid sc~t~lation counter. Acetylcho~estera~ was 
measured as in [8]. 
2.2.Product identification 
Product identification of the label incorporated 
into Sf-OSm by membrane galactosyltransferase A 
activity was carried out by alkaline cleavage: The 
assay was performed with excess amounts of enzyme 
(2.4 mg), UDF-galactose (5pmol, 10 &i/~mol 
~P-r3H]g~acto~) and exogenous acceptor (10 mg 
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Sf-GSM) under suitable conditions as described 
above. The ~cubation lasted 48 h at 3O’C; NaNs 
(0.02% w/v) was added to prevent microbial growth. 
After the incubation, the unreacted UDP-galactose 
was separated from the protein by extensive dialysis 
at 4’C. The insoluble proteins (membranes) were 
sedimented thereafter (45 000 X g, 60 mm) and the 
supernatant, containing the enzymatically labeled 
Sf-OSM was recovered and subjected to a modified 
alkaline-borohydride tr atment as in [9] . This 
procedure (KOH 0.1 N, NaBHa 2 M, 45°C for 16 h) 
cleaved nearly 100% label. Samples of the cleaved 
material were then subjected to acid hydrolysis (2 N 
HCl, 90 min, lOO*C), deionized over a mixed-bed 
ion-exchange column (BioRad). The product was 
identified in 2 systems, by thin-layer chromatog- 
raphy as indicated below and on high-voltage electro- 
phoresis (1% Na-tetraborate w/v, 45 V/cm, 70 min). 
55% of the label could be identified as galactose in
these systems. 
UDP-g~acto~:ov~bum~ g actosyltr~sfera~ 
(GT-B; EC 2.4.1.38) and a~tylcho~esterase (EC 
3 1 .I -1.7). Mean values of these enzyme activities are 
given in table 1. Since erythrocyte membrane GT-A 
has not been described before, some requirements for 
maximum activity, stability and the app. Km values 
for Mn’+, UDP-galactose and Sf-OSM have been 
determined. They are given in table 2. 
As can be noted from table 1, the normal ranges 
for GT-A activity is relatively narrow compared to 
the range of CT-B. None of these enzymes appeared 
to correlate with M, MN and N blood types. The 
range determined for GT-B corresponds approximately 
to [l 11 where si~c-acid-g~acto~-free f tuin was 
used as a substrate for GT-B [ 111. Tn erythrocytes 
had normal GT-B activity. However, GT-A activity 
was found to be very low, whereas acetylcholinesterase 
activity was within the normal range. 
2.3. Thin layer chromatography 
This was performed on pre-coated silica gel plates 
(Merck) in eth~ol~ammo~um acetate 1 M, pH 6.9, 
for 6 h at 20°C. Standards included galactose-l- 
phosphate (B~h~ger), u~a~led UP-factor 
(Sigma), labeled UDP-[ 3HfgaIactose (Amersham) and 
galactose (Merck) as in [ 101. 
3. Results 
Figure 1 shows the dependency of GT-A product 
formation on time and amount of erythrocyte mem- 
brane protein obtained from a normal individual and 
the PMFP patient. As can be seen from the graphs and 
from table 1, the PMFP sample had low but measu- 
rable GT-A, compatible with the 7% of normal 
erythrocytes found in this patient [l] . The arrows on 
both graphs indicate the standard assay conditions. 
The low amount of endogenous acceptors present in 
normal erythrocytes may explain the deviation from 
linearity in the lower range of the curve presenting 
GT-A activity as a function of the amount of enzyme 
[121* 
Erythrocyte membranes were assayed for UDP- It was concluded from serological evidence that Tn 
galactose: Sf-OSM galactosyltransferase (CT-A), erythrocytes exhibit terminal cu-GalNAc residues [2] ; 
Table 1 
Galactosyltransferase activity in normal and Tn membranes 
Enzyme activity Controls 
(mean k SD) 
Tn membranes 
UDP-galactose: SGOSM 
galactosyltransferase @T-A) 
(pmol h--l mg-’ ) 
77.25 * 12.5 (n = 12) 6.1 
(50.8 - 110.0) 
UDP-galactose:ovalbumin 
galactosyltransferase (CT-B) 
(pmol h-’ mg-’ ) 
25.5 + 8.8(n=ll) 24.3 
( 7.9 - 35.7) 
Acetyichohnesterase 
(IU mg-’ ) 
--. 
1.81 + 0.73 (n = 22) 1.08 
( 1.06 - 3.53) 
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Table 2 
Erythrocyte membrane galactosyltransferase: r quirements and 
kinetic parameters 
.__- --. 
A. Complete systema 100 % 
Complete system minus Sf-OSM 11.7% 
Complete system minus Triton X-100 6.9% 
Complete system minus Mn2+ 16.4% 
Complete system minus Mn*+ plus Mg2* (20 mM) 8.4% 
Complete system minus Mn’+ plus Cal’ (20 mM) 9.0% 
B. Km Mn’+ 8 mM 
Km UDP-galactose 0.14 mM 
Km Sf-GSM (CT-A) 2.3 mg/ml 
Km Ovalbumin (CT-B) 2.0 mg/ml 
Km Tn membranes 0.07 mg/ml 
C. Stabilityb 
7 days kept at 4°C: 16% loss of activity 
7 days kept at -2O’C: 22% loss of activity 
a The complete assay is described in section 2 
b With respect to GT-A 
September 1978 
T:k (H) 
Fig.1. Erythrocyte membrane GT-A activity as function of 
membrane protein (left) and time of incubation (right). The 
details of the assay are given in section 2. The arrows on both 
graphs indicate the standard assay conditions. 
thus, Tn membranes should act as exogenous acceptors 
if incubated with membrane galactosyltransferase 
from a normal control. Tn membranes indeed serve as 
acceptors for galactose to a sizable xtent. Interesting- 
ly the app. Km was by l-2 orders of magnitude lower 
than for Sf-OSM, indicating a higher affinity for Tn 
erythrocyte membranes than for Sf-OSM (cf. table 2). 
Linearity of galactose transfer was observed within 
6 h and the range of enzyme concentration tested; 
this excludes possible interference of nucleotide pyro- 
phosphatase activity [13,14] or extensive chemical 
breakdown of UDP-galactose [ 15 ] under the condi- 
tions chosen. In order to quantify for these effects we 
incubated normal and Tn membranes under standard 
conditions but without exogenous acceptor. At zero 
time and after 4 h aliquots were subjected to thin- 
layer chromatography as described above. Under the 
conditions of our incubation o increase of label 
corresponding to gal-l-phosphate was observed either 
in the control or in Tn erythrocyte membranes after 
4 h. However, up to SC% of the initial label of UDP- 
[3H]galactose co-chromatographed with free galactose, 
indicating chemical breakdown of the sugar nucleotide 
to an extent, though, which did not affect the substrate 
saturation of the transferase. 
4. Discussion 
We describe here a galactosyltransferase ctivity 
in normal erythrocytes which incorporates galactose 
into alkali-labile carbohydrate moieties of Sf-OSM 
(GT-A); this enzyme clearly differs from GT-B which 
is specific for GlcNAc residues as shown [ 111. They 
also measured GT-A but detected only very low 
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activity; since they did not indicate the assay condi- 
tions, we are not able to explain this discrepancy. 
Tn erythrocytes lack GT-A activity and the 
presumed product of this enzyme, the T antigen. 
Sf-OSM which unifo~y exposes GalNAc residues 
171 is a very potent inhibitor of the Tn antigen [4]. 
Thus, Sf-OSM appeared to be a suitable acceptor for 
the corresponding galactosyltransferase. The absence 
of both galactosyltransferase A and its presumed 
product in Tn erythrocytes trongly suggests hat this 
enzyme is indeed involved in the biosynthesis of the 
T antigen. 
Moreover, we have found CT-A activity in the 
serum (unpublished results) of the individual whose 
erythrocytes lack this enzyme; therefore we assume 
that GT-A deficiency is confmed to the erythroid cell 
line, perhaps as a con~quence of a somatic mutation, 
as already proposed [1) . The availability of this 
enzyme deficiency model suggests hat galactosyl- 
transferase A is involved in the biosynthesis of the M 
and N antigen precursors [ 141. Sf-OSM as an exoge- 
nous substrate renders the study of this enzyme asy 
and may form a useful approach for further studies 
on biosynthesis of cell surface antigens. 
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